Last updated: April 6, 2024
Sponsor: Damascus University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Hypercholesterolemia
Cardiovascular Disease
Atherosclerosis
Treatment
Re-infusion of unwashed shed blood
Clinical Study ID
NCT06358079
258
Ages 40-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- All patients undergoing isolated off-pump coronary artery bypass surgery between March 1st, 2024 and March 31st, 2026.
Exclusion
Exclusion Criteria:
- Missing data.
- Patients outside the study period.
- Patients under the age of 40 years or over the age of 75 years.
- Patients with impaired left ventricular function (EF less the 40%).
- Patients with history of renal failure, hepatic failure, CVA, or TIA.
- Patients who have not stopped anticoagulants (except aspirin) for 4 dayspreoperatively.
- Emergency operations.
Study Design
Total Participants: 50
Treatment Group(s): 1
Primary Treatment: Re-infusion of unwashed shed blood
Phase:
Study Start date:
March 27, 2024
Estimated Completion Date:
March 30, 2026
Study Description
Connect with a study center
Damascus University Cardiac Surgery Hospital
Damascus,
Syrian Arab RepublicActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.